Scheifele DW. Postmarketing surveillance of adverse reactions to ProHIBit vaccine in British Columbia. Canadian Medical Association Journal 1989;141:927-929.

Schlech WF, Ward JI, Bard JD. Bacterial meningitis in the United States, 1978-81: the National Bacterial Meningitis Surveillance Study. Journal of the American Medical Association 1985;253:1749-1754.

Schlesinger Y, Granoff DM. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. Journal of the American Medical Association 1992;267:1489-1494.

Schneerson R, Rodrigues LP, Parke JC Jr, Robbins JB. Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b. Journal of Immunology 1971:107:1081-1089.

Schneerson R, Barrera O, Sutton A, Robbins JB. Preparation, characterization, and immunogenicity of H. influenzae type b polysaccharide-protein conjugates. Journal of Experimental Medicine 1980;152:361-376.

Schreiber JR, Barrus V. Cates KL, Siber GR. Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b. Journal of Infectious Diseases 1986;153:8-16.

Shackelford PG, Granoff DM. IgG subclass composition of the antibody response of healthy adults, and normal or IgG2-deficient children to immunization with H. influenzae type b polysaccharide vaccine or Hib PS-protein conjugate vaccines. Monographs in Allergy 1988;23:269-281.

Shapiro ED, Murphy TV, Wald ER, Brady CA. The protective efficacy of Haemophilus b polysaccharide vaccine. Journal of the American Medical Association 1988:260:1419-1422.

Siber GR, Santosham M, Reid GR, Thompson C, Almeido-Hill J, Morell A, et al. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children. New England Journal of Medicine 1990;323:1387-1392.

Smith DH, Madore DV, Eby RJ, Anderson PW, Insel RA, Johnson CL. Haemophilus b oligosaccharide-CRM197 and other Haemophilus b conjugate vaccines: a status report. Advances in Experimental and Medical Biology 1989;251:65-82.

Sood SK, Daum RS. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation. Pediatrics 1990;85(4 Pt 2):698-704.

Sood SK, Schreiber JR, Siber GR, Daum RS. Postvaccination susceptibility to invasive Haemophilus influenzae type b disease in infant rats. Journal of Pediatrics 1988;113:814-819.

Spinola SM, Sheaffer CI, Philbrick KB, Gilligan PH. Antigenuria after Haemophilus influenzae type b polysaccharide immunization: a prospective study. Journal of Pediatrics 1986;109:835-838.

Steinhoff MC, Auerbach BS, Nelson KE, Vlahov D, Becker RL, Graham NMH, et al. Antibody responses to Haemophilus influenzae type b vaccines in men with human immunodeficiency virus infection. New England Journal of Medicine 1991:325:1837-1842.

Syrogiannopoulos GA, Hansen EJ, Erwin AL, et al. Haemophilus influenzae type b lipooligosaccharide induced meningeal inflammation. Journal of Infectious Diseases 1988;157:237-244.

Takala AK, Eskola J, Leinonen M, Kayhty H, Nissinen A, Pekkanen E, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. Journal of Infectious Diseases 1991;164:982-986.

Thomas GA, O'Brien RT. Thrombocytosis in children with Haemophilus influenzae meningitis. Clinical Pediatrics 1986;25:610-611.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement